Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 505 of 5804
-
Common antifungal drug shows promise against esophageal cancer
Disease control Recruiting nowEsophageal cancer, which has a low 5-year overall survival rate (\<20%) is increasing in incidence. Previous studies have shown that Hedgehog, AKT, and angiogenic signaling pathways are activated in a significant number of esophageal cancers. Itraconazole, a widely used anti-fung…
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Could a gut zapping procedure free diabetics from insulin?
Disease control OngoingThe purpose of this study is to determine whether RFVA of the duodenal mucosa with or without the combination of Semaglutide is a safe and effective treatment to remove the need for insulin therapy among patients with T2D who are on stable doses of insulin.
Phase: NA • Sponsor: Aqua Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New MRI scan could predict pancreatic cancer treatment success
Diagnosis Recruiting nowThis study evaluates an investigational scan called hyperpolarized carbon-13 pyruvate magnetic resonance imaging (MRI) in assessing treatment response in patients with pancreatic ductal carcinoma (PDA) that has spread to nearby tissue or lymph nodes (locally advanced) or that has…
Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC
-
New cocktail of four drugs hopes to fight Hard-to-Treat bile duct cancer
Disease control Recruiting nowThis is a multicenter Phase 1b/2 clinical trial investigating the efficacy and safety of a combination regimen of Gemcitabine, Cisplatin, Nab-paclitaxel, and Tislelizumab in treatment-naïve patients with unresectable, locally advanced, or metastatic biliary tract cancers (BTC), i…
Sponsor: CHA University • Aim: Disease control
Last updated Jun 26, 2026 16:55 UTC
-
New 3D imaging could sharpen cancer diagnosis
Diagnosis Recruiting nowThis project aims to employ a sample preprocessing system in conjunction with three-dimensional imaging techniques to generate morphologically more complete, high-resolution datasets for lung and colorectal cancers. Building on systematic experimental optimization of the preproce…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
New hope for diabetic nerve pain: phase 3 trial launches
Symptom relief Recruiting nowThe purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN).
Phase: PHASE3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Mind-Reading device may give voice to unconscious patients
Knowledge-focused ENROLLING_BY_INVITATIONThe goal of this clinical trial is to test how effective the mindBEAGLE device is in allowing people who are unconscious (due to a brain injury or other condition) to communicate using brain waves to answer Yes/No questions. Participants will wear a cap that will be connected to …
Phase: NA • Sponsor: Amy Wagner • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
New combo therapy offers hope for cancer patients who Can't breathe
Disease control Recruiting nowThis phase I/II trial studies the side effects of interstitial photodynamic therapy following palliative radiotherapy and how well it works in treating patients with inoperable malignant central airway obstruction. Patients who have advanced stage cancer tumors in the lung can of…
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can a Three-Drug cocktail shrink stomach tumors before surgery?
Disease control OngoingFor locally advanced gastric and gastroesophageal junction adenocarcinoma (cT3-4bNanyM0), perioperative PD-1 antibody combined with chemotherapy can downstage tumor stage, increase the R0 resection rate, and may improve the long-term survival. Combination of perioperative surufat…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New asthma drug could help patients ditch their daily inhalers
Disease control OngoingThe objective of this study is to assess the potential for tezepelumab-treated patients (subcutaneous administration) to reduce maintenance therapy without loss of asthma control in adolescent and adults with severe asthma.. Study details include: 1. The study duration will be …
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo aims to stop lymphoma relapse after powerful treatments
Disease control OngoingThis phase II trial tests how well pembrolizumab and tazemetostat work to treat patients who have received autologous stem cell transplantation (ASCT) or chimeric antigen receptor (CAR) T cell therapy for aggressive non hodgkins lymphoma. A monoclonal antibody, such as pembrolizu…
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug combo shows promise for early anal cancer
Disease control Recruiting nowA single arm phase II study of pembrolizumab, carboplatin, paclitaxel, and radiation for the treatment of early-stage anal cancer. There are 2 treatments phases and then surveillance. The first treatment phase is the chemoradiation phase (Cycle 1-6, weekly cycles) which is follow…
Phase: PHASE2 • Sponsor: Dustin Deming • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Double attack on Alzheimer's: new drug combo targets tau and amyloid
Disease control OngoingThe primary objective of the study is to determine the dose response of E2814, when concurrently administered with lecanemab, on the change from baseline at 6 months in cerebrospinal fluid (CSF) microtubule-binding region (MTBR)-tau-243 in participants with early Alzheimer's dise…
Phase: PHASE2 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New combo therapy offers hope for hard-to-treat stomach cancer
Disease control Recruiting nowDespite recent advances, the prognosis of patients with advanced gastric cancer remains poor. At present, regimens that combine a platinum and fluorouracil agent either alone or in combination with a third drug such as epirubicin or taxane constitute the most effective treatment …
Phase: PHASE1, PHASE2 • Sponsor: Jeeyun Lee • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New Immunotherapy-Chemo combo aims to tackle rare sarcoma
Disease control Recruiting nowSoft tissue sarcoma (STS) is a rare, highly heterogeneous malignancy with a poor prognosis. The standard first-line treatment for advanced patients is anthracyclines (doxorubicin, A) combined with ifosfamide (I, AI regimen), but the efficacy is limited, and some subtypes do not r…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New heart procedure aims to stop persistent AFib in its tracks
Disease control OngoingPulsed field ablation (PFA) has demonstrated favorable safety and efficacy in atrial fibrillation ablation, particularly for pulmonary vein isolation (PVI). However, the optimal PFA-based ablation strategy for non-paroxysmal atrial fibrillation remains uncertain. In addition to a…
Phase: NA • Sponsor: Xu Liu • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo therapy targets both psoriasis and obesity in major trial
Disease control CompletedThe main purpose of this study is to demonstrate that when participants with moderate to severe plaque psoriasis and obesity or overweight in the presence of at least 1 weight-related comorbid condition receive ixekizumab and tirzepatide concomitantly administered, participants s…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Social media ban on teen phones tested in landmark experiment
Knowledge-focused Recruiting nowThe mental health of adolescents in the United States has seen a steep decline, roughly coinciding with the increasing popularity of social media and smartphones. But does social media have a causal impact on the mental health of adolescents or are concerns about the effect of so…
Phase: NA • Sponsor: Georgetown University • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Radiation and immunotherapy combo before lung cancer surgery shows promise in early trial
Disease control TerminatedThe Window-of-Opportunity (WOO) Network is a collaboration among Ontario's doctors and scientists to conduct clinical trials in newly-diagnosed cancer patients before they have surgery with an initial focus on understanding how cancer drugs can impact the immune system. There is…
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New combo aims for deeper remission in older leukemia patients
Disease control Recruiting nowThis phase II MyeloMATCH treatment trial compares the usual treatment of azacitidine and venetoclax to the combination treatment of azacitidine, venetoclax and gilteritinib in treating older and unfit patients with acute myeloid leukemia and FLT3 mutations. Azacitidine is a drug …
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC